Literature DB >> 12383866

Substance P (NK(1)) receptor expression by human colonic epithelial cell line Caco-2.

S Böckmann1.   

Abstract

The peptide substance P (SP) is known to take part in the regulation of the Cl(-)-dependent secretion in the animal and human colonic mucosa. However, no conclusive evidence for the expression of the functional tachykinin NK(1) receptor has been found in the human colonic epithelial cells. Using the reverse transcription-polymerase chain reaction (RT-PCR) method we could detect the transcripts of the NK(1) receptor in the human colonic epithelial cell line Caco-2. Furthermore, we characterized the mechanism of substance P-induced intracellular signaling in Caco-2 cells. While substance P had no effect on intracellular calcium concentration as measured by fura-2 AM, it induced the activation of the mitogen-activated protein kinases (MAPKs) in a time- and dose-dependent manner. Surprisingly, the peptide NK(1) receptor antagonist [D-Pro(2), D-Trp(7,9)]SP stimulated the activity of MAPKs in the same manner as substance P. In contrast, the specific nonpeptide NK(1) receptor antagonist CP-96,345 clearly abolished the effect of substance P and [D-Pro(2), D-Trp(7,9)]SP on MAPK activity. CP-96,345 itself did not increase the activity of MAPKs. Thus, we provide the first evidence that a functional NK(1) receptor is expressed in the human colonic epithelial cell line Caco-2. The results show that in Caco-2 cells the peptide antagonist [D-Pro(2), D-Trp(7,9)]SP acts as a NK(1) receptor agonist in contrast to the nonpeptide antagonist CP-96,345.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383866     DOI: 10.1016/s0196-9781(02)00135-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Substance P regulates migration in rat intestinal epithelial cells.

Authors:  Douglas J Turner; Paul C Martin; Jaladanki N Rao; Jose Greenspon; Tongtong Zou; Barbara L Bass; Jian-Ying Wang; Eric D Strauch
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

2.  Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).

Authors:  Irene Chernova; Jian-Ping Lai; Haiying Li; Lynnae Schwartz; Florin Tuluc; Helen M Korchak; Steven D Douglas; Laurie E Kilpatrick
Journal:  J Leukoc Biol       Date:  2008-10-03       Impact factor: 4.962

3.  Substance P induces intestinal wound healing via fibroblasts--evidence for a TGF-beta-dependent effect.

Authors:  Peter Felderbauer; Kerem Bulut; Karoline Hoeck; Susanne Deters; Wolfgang E Schmidt; Peter Hoffmann
Journal:  Int J Colorectal Dis       Date:  2007-05-23       Impact factor: 2.571

Review 4.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

5.  Substance P failed to reverse dextran sulfate sodium-induced murine colitis mediated by mitochondrial dysfunction: implications in ulcerative colitis.

Authors:  Spoorthi B Chandraiah; Shashwati Ghosh; Ishita Saha; Sunil S More; Gautham S Annappa; Arpan K Maiti
Journal:  3 Biotech       Date:  2021-03-29       Impact factor: 2.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.